Calculating the ROI of Systematic Denial Management
Practice administrators know that denials cost money. What they often do not know — with any precision — is how much. The total cost of claim denials extends far beyond the face value of the denied claims themselves. It includes the labor cost of reworking each denial, the opportunity cost of staff time diverted from other revenue cycle tasks, the permanent revenue loss from denials that are never appealed or that expire past timely filing deadlines, and the downstream impact on cash flow and financial planning. Until a practice quantifies these costs, it cannot make rational decisions about how much to invest in denial prevention and management.
The Components of Denial Cost
A complete denial cost calculation includes five components. Most practices track only the first one.
1. Face Value of Denied Claims
This is the most visible number: the total dollar amount of claims denied in a given period. If a practice receives 300 denials per month with an average expected reimbursement of $225, the face value of denials is $67,500 per month or $810,000 annually. This is the number that appears on reports and gets discussed in meetings. It is also the least useful number in isolation because it does not account for recoveries or costs.
2. Rework Cost Per Denial
Every denied claim that gets appealed consumes staff time. Industry data from MGMA and the Healthcare Financial Management Association estimates the average cost to rework a single denial at $25 to $118, depending on the denial type and the staff involved. A straightforward eligibility correction might take 10 minutes of a billing specialist's time. A medical necessity appeal that requires pulling clinical records, drafting a letter, obtaining a provider attestation, and submitting through the payer portal might consume two hours of combined staff and provider time. Using a blended average of $35 per denial for a small practice — conservative by most estimates — the rework cost for 300 monthly denials is $10,500 per month.
3. Recovery Rate
Not every denied claim is appealed, and not every appeal is successful. The AMA reports that approximately 50% to 65% of appealed claims are eventually overturned. But the operative word is "appealed." Many practices appeal fewer than half of their denials due to staff capacity constraints, unclear appeal processes, or the assumption that the denial is valid. A practice with a 300-denial monthly volume, a 50% appeal rate, and a 60% overturn rate recovers 90 of those 300 denials. The other 210 — 70% of the total — represent permanent revenue loss.
4. Permanent Revenue Loss
Permanent revenue loss is the portion of denied claims that is never recovered. Using the example above: 210 unrecovered denials at $225 average value equals $47,250 per month or $567,000 annually. This is money that was earned through clinical work, billed correctly in most cases, and lost due to operational failures in the denial management process. It is the number that should keep practice administrators up at night.
5. Opportunity Cost
Staff time spent on denial rework is time not spent on tasks that prevent future denials or accelerate revenue collection. If your billing team spends 30% of their productive hours on denial management, they are not performing proactive AR follow-up, eligibility verification improvements, or charge capture audits. The opportunity cost is difficult to quantify precisely but is real and significant. Practices that reduce denial volume typically see improvements in other revenue cycle metrics as staff capacity is redirected to preventive work.
Building Your Practice's ROI Model
With these components defined, a practice can build a straightforward ROI model for denial management investment. The model answers a simple question: if we spend X dollars improving our denial management capability, what is the expected financial return?
Step 1: Establish Your Baseline
Calculate your current state using the five components above. You need:
- Monthly denial volume (count of denied claims)
- Average denied claim value
- Current appeal rate (percentage of denials appealed)
- Current overturn rate (percentage of appeals that succeed)
- Estimated rework cost per denial
Pull these numbers from your practice management system and billing records. Three months of data provides a reasonable baseline. If you cannot produce these numbers from your current systems, that itself is a finding — you are managing a six-figure problem without measurement.
Step 2: Model the Improvement Scenarios
Denial management investments typically improve one or more of three metrics: the denial rate itself (prevention), the appeal rate (more denials get worked), or the overturn rate (appeals are more effective). Model each scenario independently.
Prevention scenario: If you reduce your denial rate from 8% to 5% on a base of 5,000 monthly claims, you prevent 150 denials per month. At $225 average value, that is $33,750 in claims that no longer need to be reworked. The value is both the preserved revenue and the eliminated rework cost.
Recovery scenario: If you increase your appeal rate from 50% to 80% and maintain a 60% overturn rate, you recover an additional 54 claims per month on a base of 300 denials. At $225 average value, that is $12,150 per month in incremental recovered revenue.
Effectiveness scenario: If you improve your overturn rate from 60% to 75% through better appeal writing and clinical documentation support, you recover an additional 22.5 claims per month (assuming 50% appeal rate on 300 denials). That is approximately $5,063 per month in incremental recovered revenue.
Step 3: Compare Investment to Return
The investment side of the equation includes any combination of: additional staff or contracted resources, technology tools (denial tracking software, claim scrubbing, automated workflow), training programs for existing staff, and consulting or audit services. Total these costs on a monthly basis and compare to the modeled monthly improvement. The ROI calculation is straightforward:
Monthly ROI = (Monthly revenue improvement + Monthly rework cost savings - Monthly investment cost) / Monthly investment cost
What the Numbers Typically Show
In practice, denial management investments almost always show positive ROI when measured honestly. The reason is simple: the baseline cost of doing nothing is very high. A practice losing $500,000 or more annually to unrecovered denials can often recover 30% to 50% of that amount through targeted interventions that cost a fraction of the recovered revenue. Even modest improvements — reducing the denial rate by two percentage points, increasing the appeal rate by 20 points, or improving the overturn rate by 10 points — translate into five- and six-figure annual returns for most practices.
The practices that struggle to show positive ROI are typically those that invest in broad, unfocused solutions without first understanding their specific denial patterns. Buying expensive software to solve a problem that is actually rooted in provider documentation, or hiring additional staff without addressing the workflow issues that make current staff inefficient, produces disappointing returns. The ROI model works best when the investment is targeted at the specific drivers of your denial volume.
Beyond the Spreadsheet
The financial ROI model captures the quantifiable benefits of denial management investment, but there are additional benefits that are harder to measure: reduced staff burnout from less rework, improved provider satisfaction when their clinical work is properly reimbursed, better payer relationships when claims are cleaner, and more predictable cash flow for financial planning. These factors do not appear in the spreadsheet, but they contribute to the overall operational health of the practice.
The starting point is measurement. Know your numbers, model your scenarios, and make investment decisions based on data rather than intuition. The practices that treat denial management as a measurable business function — rather than an unavoidable cost of doing business — consistently achieve better financial outcomes.